Remogliflozin A
Modify Date: 2024-01-10 11:26:29
Remogliflozin A structure
|
Common Name | Remogliflozin A | ||
|---|---|---|---|---|
| CAS Number | 329045-45-6 | Molecular Weight | 450.53 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C23H34N2O7 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Remogliflozin ARemogliflozin is a potent and selective inhibitor of SGLT2 (sodium-glucose cotransporter 2) with Kis of 12.4 and 26 nM for human and rat SGLT2, respectively[1]. |
| Name | (2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[5-methyl-1-propan-2-yl-4-[(4-propan-2-yloxyphenyl)methyl]pyrazol-3-yl]oxyoxane-3,4,5-triol |
|---|---|
| Synonym | More Synonyms |
| Description | Remogliflozin is a potent and selective inhibitor of SGLT2 (sodium-glucose cotransporter 2) with Kis of 12.4 and 26 nM for human and rat SGLT2, respectively[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C23H34N2O7 |
|---|---|
| Molecular Weight | 450.53 |
| Exact Mass | 450.23700 |
| PSA | 126.43000 |
| LogP | 1.32910 |
|
~%
Remogliflozin A CAS#:329045-45-6 |
| Literature: GLAXOSMITHKLINE LLC; MARTIN, Michael Tolar; MCCLURE, Michael S; ELITZIN, Vassil Patent: WO2010/59774 A1, 2010 ; Location in patent: Page/Page column 26-27 ; WO 2010/059774 A1 |
| Remogliflozin A |
| UNII-13ZPK7A4MJ |
| [14C]-Remogliflozin |